Evidence map›Paper›PMID 39359710›Full record

ArticleNeurology. Education2023

The Neuromuscular Portal and Match: Working Toward a More Fair, Equitable, and Transparent Process.

Ruple S Laughlin, Shirlyn Adkins, Michael Baer, Sara Dehbashi, Karissa Gable, Raghav Govindarajan, Amanda C Guidon, Kelly G Gwathmey, Michael K Hehir, Matthew Imperioli and 6 more

Erratum issuedAbstract read
In one paragraph

Article in Neurology. Education, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Missing Full Disclosures.Neurology. Education · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Ruple S LaughlinFrom the Mayo Clinic (R.S.L.); AANEM (S.A., J.S.), Rochester, MN; University of Pennsylvania (M.B., R.S.P.); Thomas Jefferson University (S.D., E.S.W.), Philadelphia, PA; Duke University (K.G.), Durham, NC; University of Missouri (R.G.), St. Louis; Department of Neurology (A.C.G.), Harvard Medical School/Massachusetts General Hospital, Boston, MA; Virginia Commonwealth University (K.G.G.), Richmond; University of Vermont (M.K.H.), Burlington; University of Connecticut (M.I.), Storrs; Department of Neurological Sciences (S.S.), Stanford University, Stanford, CA; Keck USC College of Medicine (N.T.), Los Angeles, CA; and University of Michigan (Z.L.), Ann Arbor.ORCID https://orcid.org/0000-0002-1884-5824
Shirlyn AdkinsFrom the Mayo Clinic (R.S.L.); AANEM (S.A., J.S.), Rochester, MN; University of Pennsylvania (M.B., R.S.P.); Thomas Jefferson University (S.D., E.S.W.), Philadelphia, PA; Duke University (K.G.), Durham, NC; University of Missouri (R.G.), St. Louis; Department of Neurology (A.C.G.), Harvard Medical School/Massachusetts General Hospital, Boston, MA; Virginia Commonwealth University (K.G.G.), Richmond; University of Vermont (M.K.H.), Burlington; University of Connecticut (M.I.), Storrs; Department of Neurological Sciences (S.S.), Stanford University, Stanford, CA; Keck USC College of Medicine (N.T.), Los Angeles, CA; and University of Michigan (Z.L.), Ann Arbor.
Michael BaerFrom the Mayo Clinic (R.S.L.); AANEM (S.A., J.S.), Rochester, MN; University of Pennsylvania (M.B., R.S.P.); Thomas Jefferson University (S.D., E.S.W.), Philadelphia, PA; Duke University (K.G.), Durham, NC; University of Missouri (R.G.), St. Louis; Department of Neurology (A.C.G.), Harvard Medical School/Massachusetts General Hospital, Boston, MA; Virginia Commonwealth University (K.G.G.), Richmond; University of Vermont (M.K.H.), Burlington; University of Connecticut (M.I.), Storrs; Department of Neurological Sciences (S.S.), Stanford University, Stanford, CA; Keck USC College of Medicine (N.T.), Los Angeles, CA; and University of Michigan (Z.L.), Ann Arbor.
Sara DehbashiFrom the Mayo Clinic (R.S.L.); AANEM (S.A., J.S.), Rochester, MN; University of Pennsylvania (M.B., R.S.P.); Thomas Jefferson University (S.D., E.S.W.), Philadelphia, PA; Duke University (K.G.), Durham, NC; University of Missouri (R.G.), St. Louis; Department of Neurology (A.C.G.), Harvard Medical School/Massachusetts General Hospital, Boston, MA; Virginia Commonwealth University (K.G.G.), Richmond; University of Vermont (M.K.H.), Burlington; University of Connecticut (M.I.), Storrs; Department of Neurological Sciences (S.S.), Stanford University, Stanford, CA; Keck USC College of Medicine (N.T.), Los Angeles, CA; and University of Michigan (Z.L.), Ann Arbor.
Karissa GableFrom the Mayo Clinic (R.S.L.); AANEM (S.A., J.S.), Rochester, MN; University of Pennsylvania (M.B., R.S.P.); Thomas Jefferson University (S.D., E.S.W.), Philadelphia, PA; Duke University (K.G.), Durham, NC; University of Missouri (R.G.), St. Louis; Department of Neurology (A.C.G.), Harvard Medical School/Massachusetts General Hospital, Boston, MA; Virginia Commonwealth University (K.G.G.), Richmond; University of Vermont (M.K.H.), Burlington; University of Connecticut (M.I.), Storrs; Department of Neurological Sciences (S.S.), Stanford University, Stanford, CA; Keck USC College of Medicine (N.T.), Los Angeles, CA; and University of Michigan (Z.L.), Ann Arbor.
Raghav GovindarajanFrom the Mayo Clinic (R.S.L.); AANEM (S.A., J.S.), Rochester, MN; University of Pennsylvania (M.B., R.S.P.); Thomas Jefferson University (S.D., E.S.W.), Philadelphia, PA; Duke University (K.G.), Durham, NC; University of Missouri (R.G.), St. Louis; Department of Neurology (A.C.G.), Harvard Medical School/Massachusetts General Hospital, Boston, MA; Virginia Commonwealth University (K.G.G.), Richmond; University of Vermont (M.K.H.), Burlington; University of Connecticut (M.I.), Storrs; Department of Neurological Sciences (S.S.), Stanford University, Stanford, CA; Keck USC College of Medicine (N.T.), Los Angeles, CA; and University of Michigan (Z.L.), Ann Arbor.
Amanda C GuidonFrom the Mayo Clinic (R.S.L.); AANEM (S.A., J.S.), Rochester, MN; University of Pennsylvania (M.B., R.S.P.); Thomas Jefferson University (S.D., E.S.W.), Philadelphia, PA; Duke University (K.G.), Durham, NC; University of Missouri (R.G.), St. Louis; Department of Neurology (A.C.G.), Harvard Medical School/Massachusetts General Hospital, Boston, MA; Virginia Commonwealth University (K.G.G.), Richmond; University of Vermont (M.K.H.), Burlington; University of Connecticut (M.I.), Storrs; Department of Neurological Sciences (S.S.), Stanford University, Stanford, CA; Keck USC College of Medicine (N.T.), Los Angeles, CA; and University of Michigan (Z.L.), Ann Arbor.
Kelly G GwathmeyFrom the Mayo Clinic (R.S.L.); AANEM (S.A., J.S.), Rochester, MN; University of Pennsylvania (M.B., R.S.P.); Thomas Jefferson University (S.D., E.S.W.), Philadelphia, PA; Duke University (K.G.), Durham, NC; University of Missouri (R.G.), St. Louis; Department of Neurology (A.C.G.), Harvard Medical School/Massachusetts General Hospital, Boston, MA; Virginia Commonwealth University (K.G.G.), Richmond; University of Vermont (M.K.H.), Burlington; University of Connecticut (M.I.), Storrs; Department of Neurological Sciences (S.S.), Stanford University, Stanford, CA; Keck USC College of Medicine (N.T.), Los Angeles, CA; and University of Michigan (Z.L.), Ann Arbor.
Michael K HehirFrom the Mayo Clinic (R.S.L.); AANEM (S.A., J.S.), Rochester, MN; University of Pennsylvania (M.B., R.S.P.); Thomas Jefferson University (S.D., E.S.W.), Philadelphia, PA; Duke University (K.G.), Durham, NC; University of Missouri (R.G.), St. Louis; Department of Neurology (A.C.G.), Harvard Medical School/Massachusetts General Hospital, Boston, MA; Virginia Commonwealth University (K.G.G.), Richmond; University of Vermont (M.K.H.), Burlington; University of Connecticut (M.I.), Storrs; Department of Neurological Sciences (S.S.), Stanford University, Stanford, CA; Keck USC College of Medicine (N.T.), Los Angeles, CA; and University of Michigan (Z.L.), Ann Arbor.
Matthew ImperioliFrom the Mayo Clinic (R.S.L.); AANEM (S.A., J.S.), Rochester, MN; University of Pennsylvania (M.B., R.S.P.); Thomas Jefferson University (S.D., E.S.W.), Philadelphia, PA; Duke University (K.G.), Durham, NC; University of Missouri (R.G.), St. Louis; Department of Neurology (A.C.G.), Harvard Medical School/Massachusetts General Hospital, Boston, MA; Virginia Commonwealth University (K.G.G.), Richmond; University of Vermont (M.K.H.), Burlington; University of Connecticut (M.I.), Storrs; Department of Neurological Sciences (S.S.), Stanford University, Stanford, CA; Keck USC College of Medicine (N.T.), Los Angeles, CA; and University of Michigan (Z.L.), Ann Arbor.
Raymond S PriceFrom the Mayo Clinic (R.S.L.); AANEM (S.A., J.S.), Rochester, MN; University of Pennsylvania (M.B., R.S.P.); Thomas Jefferson University (S.D., E.S.W.), Philadelphia, PA; Duke University (K.G.), Durham, NC; University of Missouri (R.G.), St. Louis; Department of Neurology (A.C.G.), Harvard Medical School/Massachusetts General Hospital, Boston, MA; Virginia Commonwealth University (K.G.G.), Richmond; University of Vermont (M.K.H.), Burlington; University of Connecticut (M.I.), Storrs; Department of Neurological Sciences (S.S.), Stanford University, Stanford, CA; Keck USC College of Medicine (N.T.), Los Angeles, CA; and University of Michigan (Z.L.), Ann Arbor.ORCID https://orcid.org/0000-0002-9496-0488
Sarada SakamuriFrom the Mayo Clinic (R.S.L.); AANEM (S.A., J.S.), Rochester, MN; University of Pennsylvania (M.B., R.S.P.); Thomas Jefferson University (S.D., E.S.W.), Philadelphia, PA; Duke University (K.G.), Durham, NC; University of Missouri (R.G.), St. Louis; Department of Neurology (A.C.G.), Harvard Medical School/Massachusetts General Hospital, Boston, MA; Virginia Commonwealth University (K.G.G.), Richmond; University of Vermont (M.K.H.), Burlington; University of Connecticut (M.I.), Storrs; Department of Neurological Sciences (S.S.), Stanford University, Stanford, CA; Keck USC College of Medicine (N.T.), Los Angeles, CA; and University of Michigan (Z.L.), Ann Arbor.
Jacob SokolFrom the Mayo Clinic (R.S.L.); AANEM (S.A., J.S.), Rochester, MN; University of Pennsylvania (M.B., R.S.P.); Thomas Jefferson University (S.D., E.S.W.), Philadelphia, PA; Duke University (K.G.), Durham, NC; University of Missouri (R.G.), St. Louis; Department of Neurology (A.C.G.), Harvard Medical School/Massachusetts General Hospital, Boston, MA; Virginia Commonwealth University (K.G.G.), Richmond; University of Vermont (M.K.H.), Burlington; University of Connecticut (M.I.), Storrs; Department of Neurological Sciences (S.S.), Stanford University, Stanford, CA; Keck USC College of Medicine (N.T.), Los Angeles, CA; and University of Michigan (Z.L.), Ann Arbor.
Noelle TiongsonFrom the Mayo Clinic (R.S.L.); AANEM (S.A., J.S.), Rochester, MN; University of Pennsylvania (M.B., R.S.P.); Thomas Jefferson University (S.D., E.S.W.), Philadelphia, PA; Duke University (K.G.), Durham, NC; University of Missouri (R.G.), St. Louis; Department of Neurology (A.C.G.), Harvard Medical School/Massachusetts General Hospital, Boston, MA; Virginia Commonwealth University (K.G.G.), Richmond; University of Vermont (M.K.H.), Burlington; University of Connecticut (M.I.), Storrs; Department of Neurological Sciences (S.S.), Stanford University, Stanford, CA; Keck USC College of Medicine (N.T.), Los Angeles, CA; and University of Michigan (Z.L.), Ann Arbor.
Ericka S WongFrom the Mayo Clinic (R.S.L.); AANEM (S.A., J.S.), Rochester, MN; University of Pennsylvania (M.B., R.S.P.); Thomas Jefferson University (S.D., E.S.W.), Philadelphia, PA; Duke University (K.G.), Durham, NC; University of Missouri (R.G.), St. Louis; Department of Neurology (A.C.G.), Harvard Medical School/Massachusetts General Hospital, Boston, MA; Virginia Commonwealth University (K.G.G.), Richmond; University of Vermont (M.K.H.), Burlington; University of Connecticut (M.I.), Storrs; Department of Neurological Sciences (S.S.), Stanford University, Stanford, CA; Keck USC College of Medicine (N.T.), Los Angeles, CA; and University of Michigan (Z.L.), Ann Arbor.
Zachary LondonFrom the Mayo Clinic (R.S.L.); AANEM (S.A., J.S.), Rochester, MN; University of Pennsylvania (M.B., R.S.P.); Thomas Jefferson University (S.D., E.S.W.), Philadelphia, PA; Duke University (K.G.), Durham, NC; University of Missouri (R.G.), St. Louis; Department of Neurology (A.C.G.), Harvard Medical School/Massachusetts General Hospital, Boston, MA; Virginia Commonwealth University (K.G.G.), Richmond; University of Vermont (M.K.H.), Burlington; University of Connecticut (M.I.), Storrs; Department of Neurological Sciences (S.S.), Stanford University, Stanford, CA; Keck USC College of Medicine (N.T.), Los Angeles, CA; and University of Michigan (Z.L.), Ann Arbor.ORCID https://orcid.org/0000-0003-3803-2473

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prior to 2021, the neuromuscular medicine fellowship application process suffered from non-standardized timelines and substantial variability. To rectify this, the American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) established a standardized application timeline and an online application portal in 2020-2021, followed by the introduction of a partial match process. In 2021-2022, AANEM launched a traditional, binding, two-way match system for fellowship positions allocation based on the Gale-Shapley stable matching algorithm. Surveys assessing perceptions of fairness in the application portal and match process were dispatched to applicants and program directors following the 2021 and 2022 recruitment cycles. In the 2020-21 cycle, 90% of program directors and 95% of applicants affirmed the standardized timeline benefited applicants. However, 57% of applicants deemed the process as unfair. All programs and most applicants (58%) favored a transition to a two-way match. The implementation of the two-way match in 2021-22 attracted participation from 97% of programs, with 80% of applicants and 95% of programs viewing the process as fair to applicants. A significant majority of both applicants (86%) and programs (94%) supported maintaining the standardized timeline and two-way match. We advocate for the universal adoption of the AANEM Match for neuromuscular fellowship recruitment and a standardized fellowship application timeline across all neurologic specialties to promote transparency, fairness, and equity for applicants.

Identifiers

PMID39359710
PMCPMC11446161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.